Navigation Links
Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
Date:5/20/2008

MEK inhibitor for the treatment of cancer and inflammatory diseases, RDEA436, in a human micro-dose pharmacokinetic study and have selected it as a development candidate.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: sufficiency of cash resources and our goals, including the expected properties and benefits of RDEA806, RDEA427, RDEA594, RDEA119, RDEA436 and our other compounds and the results of preclinical, clinical and other studies. Risks that contribute to the uncertain nature of the forward-looking statements include: risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with internal development and business development activities. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
2. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
3. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
4. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
7. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
11. Neurocrine Biosciences Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 20, 2013 Today Moscamed made the ... of a new programme to control the dengue mosquito ... State of Bahia. In previous trials Moscamed have ... rapidly reduce the number of dengue mosquitoes in a town. ... these mosquitoes were reduced by 96% within 6 months and ...
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
Breaking Medicine Technology:Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4
... chronic idiopathic,thrombocytopenic purpura increased and maintained platelet ... with extended treatment, ATLANTA, Dec. 10 ... safety and efficacy of its investigational,drug PROMACTA(TM) ... purpura (ITP).(1) These preliminary results from the,EXTEND ...
... trial specifically designed to evaluate erectile ... function in ED patients with dyslipidemia, ... specifically designed to evaluate erectile function in,erectile dysfunction (ED) ... treating ED, significantly improves the ability,of men with ED ...
Cached Medicine Technology:Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 2Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 3Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 4New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 2New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 3New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 4New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 5
(Date:6/20/2013)... (PRWEB) June 20, 2013 Volume based ... to dramatically reduce the retail pricing of both it's ... meal replacement products. , Premier Natural Health’s whey ... natural food sources and are formulated to help maintain ... calorie intake and slow the aging process. , ...
(Date:6/20/2013)... 2013 TASC, a national leader ... new service to deal with funding the Patient-Centered ... Protection & Affordable Care Act (PPACA), the PCORI ... clinical effectiveness, and appropriateness" of different medical treatments. ... its own, with funding in part by employer-paid ...
(Date:6/20/2013)... 20, 2013 Millions of Britons are ... medical conditions because they do not brush their teeth ... Elgydium toothpaste. , Seven million Britons do not clean ... between brushes, latest data from the British Dental Health ... polled by the BDHF also admitted that they forgot ...
(Date:6/20/2013)... 20, 2013 David Icke, the highly visible ... and Radio station. , Fresh from the Bilderburg fringe ... is getting ready to launch ‘The Peoples Voice’ TV and ... is a fantastic opportunity for journalists to cover the stories ... areas of the globe. , Because this station is ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Michigan-based natural ... research work by chemist David R Hamilton which revealed ... or planned – resulted in the release of the ... entire body. Oxytocin is known as the ‘cardio protective’ ... in turn, good for heart health. , “Being kind ...
Breaking Medicine News(10 mins):Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3
... body of scientific research about probiotics was presented today ... Here To Stay?" an annual Harvard Medical School ... cutting-edge topics are selected to provide education about emerging ... providers, and this year probiotics took center stage. ...
... data can make all the difference in controlling it. ... When should counties and states shut down airports, schools, and ... school and work? As America and the world ... says it may have a solution that can save both time ...
... Affiliates, Inc. (UCIA.PK) announced that on July 6, 2009, ... the United States District Court for the District of ... Executive Vice-President of Finance, Chief Financial Officer, and Secretary ... of the Securities and Exchange Act of 1934 and ...
... Into Service , , OTTAWA, July 8 /PRNewswire-FirstCall/ ... and radiopharmaceuticals, today continued to urge the Government of ... complete the MAPLE project to address the global shortage ... AECL that the 52-year-old National Research Universal (NRU) reactor ...
... following is a statement of Matthew L. Myers, President, Campaign ... ) , , We urge North Carolina legislators ... of North Carolina families by heeding Governor Bev Perdue,s call ... budget. While a larger cigarette tax increase would produce even ...
... 2009 Elsevier, a world-leading publisher of scientific, technical ... announce that PM&R -The journal of injury, ... journal of the American Academy of Physical Medicine and ... just six months after its launch in January 2009. ...
Cached Medicine News:Health News:Harvard Medical School Continues Education About Benefits of Probiotics 2Health News:Harvard Medical School Continues Education About Benefits of Probiotics 3Health News:Harvard Medical School Continues Education About Benefits of Probiotics 4Health News:Fighting the swine flu pandemic with mathematics 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 3Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 4Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 2Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 3Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 4Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 2Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 3Health News:PM&R accepted for abstracting and indexing in MEDLINE 2
Containing more than 600 full drug monographs, plus abbreviated monographs for combination drugs, orphan drugs and AIDS drugs in development, A to Z Drug Facts provides up-to-date information on more...
Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
... System RSD 800 is an individually configurable ... tube type identification via cap recognition is ... sample tubes in a clearly organized workflow. ... customized and offer high capacity. The System ...
... RSD 800A is an individually configurable System ... tube type identification via cap recognition is ... sample tubes in a clearly organized workflow. ... customized and offer high capacity. The System ...
Medicine Products: